Pre-receptor regulation of the androgen receptor.

Mol Cell Endocrinol 2008 Jan 22;281(1-2):1-8. Epub 2007 Oct 22.

Center of Excellence in Environmental Toxicology, Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104-6084, USA.

The human androgen receptor (AR) is a ligand-activated nuclear transcription factor and mediates the induction of genes involved in the development of the male phenotype and male secondary sex characteristics, as well as the normal and abnormal growth of the prostate. We have identified the pair of hydroxysteroid dehydrogenases (HSDs) that regulate ligand access to the AR in human prostate. We find that type 3 3alpha-HSD (aldo-keto reductase (AKR)1C2) catalyzes the NADPH dependent reduction of the potent androgen 5alpha-dihydrotestosterone (5alpha-DHT) to yield the inactive androgen 3alpha-androstanediol (3alpha-diol). We also find that RoDH like 3alpha-HSD (RL-HSD) catalyzes the NAD(+) dependent oxidation of 3alpha-diol to yield 5alpha-DHT. Together these enzymes are involved in the pre-receptor regulation of androgen action. Inhibition of AKR1C2 would be desirable in cases of androgen insufficiency and inhibition of RL-HSD might be desirable in benign prostatic hyperplasia.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mce.2007.10.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225387PMC
January 2008
4 Reads

Publication Analysis

Top Keywords

androgen receptor
8
regulation androgen
8
pre-receptor regulation
8
androgen
6
androgen 5alpha-dihydrotestosterone
4
5alpha-dihydrotestosterone 5alpha-dht
4
potent androgen
4
dependent reduction
4
5alpha-dht yield
4
reduction potent
4
androgen 3alpha-androstanediol
4
3alpha-diol find
4
3alpha-androstanediol 3alpha-diol
4
nadph dependent
4
inactive androgen
4
yield inactive
4
reductase akr1c2
4
access human
4
human prostate
4
ligand access
4

Similar Publications